156 related articles for article (PubMed ID: 38773747)
21. Bioethical implications of organ-on-a-chip on modernizing drug development.
Thakar RG; Fenton KN
Artif Organs; 2023 Oct; 47(10):1553-1558. PubMed ID: 37578206
[TBL] [Abstract][Full Text] [Related]
22. Human Brain Organoids-on-Chip: Advances, Challenges, and Perspectives for Preclinical Applications.
Castiglione H; Vigneron PA; Baquerre C; Yates F; Rontard J; Honegger T
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365119
[TBL] [Abstract][Full Text] [Related]
23. Human liver organoid models for assessment of drug toxicity at the preclinical stage.
Karabicici M; Akbari S; Ertem O; Gumustekin M; Erdal E
Endocr Metab Immune Disord Drug Targets; 2023 Apr; ():. PubMed ID: 37055905
[TBL] [Abstract][Full Text] [Related]
24. Towards manufacturing of human organoids.
Ashok A; Choudhury D; Fang Y; Hunziker W
Biotechnol Adv; 2020; 39():107460. PubMed ID: 31626951
[TBL] [Abstract][Full Text] [Related]
25. Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms.
Kulkeaw K; Tubsuwan A; Tongkrajang N; Whangviboonkij N
PeerJ; 2020; 8():e9968. PubMed ID: 33133779
[TBL] [Abstract][Full Text] [Related]
26. High-throughput bioengineering of homogenous and functional human-induced pluripotent stem cells-derived liver organoids
Xu X; Jiang S; Gu L; Li B; Xu F; Li C; Chen P
Front Bioeng Biotechnol; 2022; 10():937595. PubMed ID: 36032707
[TBL] [Abstract][Full Text] [Related]
27. Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery.
Zhao H; Yan F
Stem Cell Rev Rep; 2024 Feb; 20(2):495-508. PubMed ID: 38079086
[TBL] [Abstract][Full Text] [Related]
28. Self-assembly of three-dimensional liver organoids: virtual reconstruction
Zhang Z; Wu Y; Xuan Z; Xu H; Yin S; Meng Z
Biomater Sci; 2023 Dec; 11(24):7867-7883. PubMed ID: 37902572
[No Abstract] [Full Text] [Related]
29. A Scalable Approach for the Generation of Human Pluripotent Stem Cell-Derived Hepatic Organoids with Sensitive Hepatotoxicity Features.
Sgodda M; Dai Z; Zweigerdt R; Sharma AD; Ott M; Cantz T
Stem Cells Dev; 2017 Oct; 26(20):1490-1504. PubMed ID: 28699415
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for Manufacturing and Application of Organoids: Kidney.
Kang HM; Kim DS; Kim YK; Shin K; Ahn SJ; Jung CR
Int J Stem Cells; 2024 May; 17(2):141-146. PubMed ID: 38764433
[TBL] [Abstract][Full Text] [Related]
31. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
32. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
Elife; 2020 Nov; 9():. PubMed ID: 33138918
[TBL] [Abstract][Full Text] [Related]
33.
Paradiso A; Volpi M; Rinoldi C; Celikkin N; Contessi Negrini N; Bilgen M; Dallera G; Pierini F; Costantini M; Święszkowski W; Farè S
Biomater Sci; 2023 May; 11(9):2988-3015. PubMed ID: 36468579
[TBL] [Abstract][Full Text] [Related]
34. Advanced human developmental toxicity and teratogenicity assessment using human organoid models.
Li M; Gong J; Gao L; Zou T; Kang J; Xu H
Ecotoxicol Environ Saf; 2022 Apr; 235():113429. PubMed ID: 35325609
[TBL] [Abstract][Full Text] [Related]
35. Proposal for considerations during human iPSC-derived cardiac organoid generation for cardiotoxicity drug testing.
Lee SW; Song M; Woo DH; Jeong GS
Biomed Pharmacother; 2024 May; 174():116511. PubMed ID: 38574616
[TBL] [Abstract][Full Text] [Related]
36. Development of organoid-based drug metabolism model.
Park E; Kim HK; Jee J; Hahn S; Jeong S; Yoo J
Toxicol Appl Pharmacol; 2019 Dec; 385():114790. PubMed ID: 31678242
[TBL] [Abstract][Full Text] [Related]
37. Bioprinting of Human Liver-Derived Epithelial Organoids for Toxicity Studies.
Bouwmeester MC; Bernal PN; Oosterhoff LA; van Wolferen ME; Lehmann V; Vermaas M; Buchholz MB; Peiffer QC; Malda J; van der Laan LJW; Kramer NI; Schneeberger K; Levato R; Spee B
Macromol Biosci; 2021 Dec; 21(12):e2100327. PubMed ID: 34559943
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus infection modeling using multi-cellular organoids derived from human induced pluripotent stem cells.
Cao D; Ge JY; Wang Y; Oda T; Zheng YW
World J Gastroenterol; 2021 Aug; 27(29):4784-4801. PubMed ID: 34447226
[TBL] [Abstract][Full Text] [Related]
39. Mathematical Models of Organoid Cultures.
Montes-Olivas S; Marucci L; Homer M
Front Genet; 2019; 10():873. PubMed ID: 31592020
[TBL] [Abstract][Full Text] [Related]
40. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.
van Rijt A; Stefanek E; Valente K
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
